Roswell Park Cancer Institute
Clinical trials sponsored by Roswell Park Cancer Institute, explained in plain language.
-
Triple-Drug cocktail targets Hard-to-Treat blood cancers
Disease control Not yet recruitingThis phase I trial is testing whether combining three drugs—pacritinib, venetoclax, and azacitidine—is safe and tolerable for people with accelerated or blast phase myeloproliferative neoplasms, aggressive blood cancers. The study enrolls about 20 adults whose disease has progres…
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Radiation hotspots may boost lung cancer treatment — a trial puts it to the test
Disease control Not yet recruitingThis trial compares standard stereotactic ablative radiotherapy (SBRT) to a version that intentionally delivers higher radiation doses to the tumor (hotspots) in people with early-stage non-small cell lung cancer. The goal is to see if hotspots improve local tumor control without…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can fasting two days a week slow kidney cancer? a new trial tests the idea
Disease control Not yet recruitingThis trial compares two weight-loss approaches—daily calorie restriction versus 5:2 intermittent fasting—in people with small kidney tumors who are being monitored rather than treated immediately. The goal is to see which program helps patients lose more weight and whether that m…
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Double-Pronged immune cells take aim at stubborn blood cancers
Disease control Not yet recruitingThis phase 1 trial tests an experimental therapy called 20-19 Tan BB06z CAR-T for people with certain blood cancers (like lymphoma or leukemia) that have come back or not responded to treatment. The therapy involves taking a patient's own immune T cells, genetically modifying the…
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New combo therapy targets hard-to-treat lung cancer mutation
Disease control Not yet recruitingThis study tests whether adding a cancer vaccine (CIMAVAX-EGF) to standard targeted drugs (sotorasib or adagrasib) can help control advanced lung cancer with a KRAS G12C mutation. About 29 adults with stage III or IV non-small cell lung cancer will receive the combination. The go…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New Light-Based combo tackles tough lung cancers
Disease control Not yet recruitingThis phase II trial tests a new approach for advanced non-small cell lung cancer that hasn't responded to standard treatments. It combines photoimmunotherapy (ASP-1929), a light-activated drug that targets cancer cells, with cemiplimab, an immunotherapy that boosts the immune sys…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New Micro-Ultrasound could spot prostate cancer more clearly
Diagnosis Not yet recruitingThis study tests whether a new type of ultrasound, called transperineal micro-ultrasound, can better detect prostate cancer during biopsy. Unlike standard ultrasound, this method uses higher frequency sound waves to create clearer images. Researchers will enroll 138 men scheduled…
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Simple home exercises may help Smokers' lungs
Prevention Not yet recruitingThis study tests whether home-based breathing exercises and stationary bike workouts can improve lung health in 200 current and former smokers aged 50 and older. Participants will use a handheld breathing device and a stationary bike for 12 weeks. The goal is to see if these exer…
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Magic mushroom compound tested for cancer pain relief
Symptom relief Not yet recruitingThis phase II trial tests whether low-dose psilocybin, a compound from magic mushrooms, combined with psychotherapy is safe and effective for easing chronic pain in cancer patients who already take opioids. Twenty adults with active cancer and moderate to severe pain will receive…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Could gentle yoga and breathing ease Cancer's lingering toll?
Symptom relief Not yet recruitingThis trial tests whether mind-body practices like breathwork, meditation, and gentle yoga can improve quality of life, stress, and sleep in people who have recently finished cancer treatment. Participants will practice these techniques weekly for six weeks while wearing an activi…
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Vaping nicotine before THC changes how much gets into your blood
Knowledge-focused Not yet recruitingThis study looks at how using nicotine vapes before or after THC vapes changes the amount of THC that enters the bloodstream. Researchers will compare THC levels and effects in 60 adults who regularly use both products. The goal is to understand safety and how these products work…
Phase: EARLY_PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Vaping vs. smoking weed: which delivers THC faster?
Knowledge-focused Not yet recruitingThis study will compare how quickly and how much THC enters the blood when people vape THC liquids versus smoking cannabis. Forty healthy adults who already use both products will try each method in a random order. Researchers will measure THC levels, side effects, and puffing be…
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC